Hematology-Oncology Medical Group of Fresno, Incorporated

Fresno, California 93720

0 studies enrolling now · 3 studies all time

What they study most

Multiple Myeloma and Plasma Cell Neoplasm, Refractory Plasma Cell Neoplasm, Stage II Multiple Myeloma, Stage III Multiple Myeloma

Studies at this site

• Bortezomib, Ascorbic Acid, and Melphalan in Treating Patients With Newly Diagnosed Multiple Myeloma — Completed
• Samarium 153 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma — Completed
• Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma — Withdrawn before enrolling